R-ACVBP and DA-EPOCH-R in Patients With Non-GCB DLBCL
Status:
Unknown status
Trial end date:
2021-01-01
Target enrollment:
Participant gender:
Summary
This is a randomized, open-label, multi-center, phase 3 study evaluating the efficacy of
R-ACVBP and DA-EPOCH-R in patients with newly diagnosed non-germinal b-cell-like diffuse
large B-cell lymphoma